Cargando…
Adjuvant TACE inhibitor treatment improves the outcome of TLR2(-/- )mice with experimental pneumococcal meningitis
BACKGROUND: Streptococcus (S.) pneumoniae meningitis has a high lethality despite antibiotic treatment. Inflammation is a major pathogenetic factor, which is unresponsive to antibiotics. Therefore adjunctive therapies with antiinflammatory compounds have been developed. TNF484 is a TNF-alpha convert...
Autores principales: | Echchannaoui, Hakim, Leib, Stephen L, Neumann, Ulf, Landmann, Regine MA |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855056/ https://www.ncbi.nlm.nih.gov/pubmed/17428319 http://dx.doi.org/10.1186/1471-2334-7-25 |
Ejemplares similares
-
Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
por: Blaser, Cornelia, et al.
Publicado: (2010) -
Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis
por: Østergaard, Christian, et al.
Publicado: (2010) -
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis
por: Liechti, Fabian D, et al.
Publicado: (2015) -
Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis
por: Pan, Steven D., et al.
Publicado: (2020) -
Vitamin B6 reduces hippocampal apoptosis in experimental pneumococcal meningitis
por: Zysset-Burri, Denise C, et al.
Publicado: (2013)